All In Biotech

Drug Trial Radar · NCT01542034

Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area

Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of ATX-101 (Sodium Deoxycholate Injection) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area

Last checked: Nov 19, 2026Latest source record: Jun 15, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 506 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

506

Actual

Start

Feb 2012

Primary completion

May 2013

Study completion Aug 2013

Sponsor

Lead sponsor
Kythera BiopharmaceuticalsIndustry
Sponsor type
Industry
First posted
Mar 1, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

To evaluate the safety and efficacy of deoxycholic acid injection in the reduction of submental fat (fat below the chin).

Conditions

  • Moderate or Severe Submental Fullness

Interventions

  • Deoxycholic acid injectionDrug

    Formulated as an injectable solution containing deoxycholic acid at a concentration of 10 mg/mL.

  • PlaceboDrug

    Phosphate buffered saline placebo for injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants Who Achieved a Composite 1-grade ResponseTime frame: Baseline and 12 weeks after last treatment (up to 32 weeks after first treatment)
  2. Percentage of Participants Who Achieved a Composite 2-grade ResponseTime frame: Baseline and 12 weeks after last treatment (up to 32 weeks after first treatment)

Locations

36 sites in 2 countries. Site status is shown where the registry gives one.

  • Investigational Site

    Birmingham, Alabama

  • Investigational Site

    Beverly Hills, California

  • Investigational Site

    Beverly Hills, California

  • Investigational Site

    Irvine, California

  • Investigational Site

    Los Angeles, California

  • Investigational Site

    Oceanside, California

  • Investigational Site

    San Diego, California

  • Investigational Site

    San Diego, California

  • Investigational Site

    New Haven, Connecticut

  • Investigational Site

    Washington D.C., District of Columbia

  • Investigational Site

    Miami Beach, Florida

  • Investigational Site

    West Palm Beach, Florida

  • Investigational Site

    Atlanta, Georgia

  • Investigational Site

    Snellville, Georgia

  • Investigational Site

    Arlington, Illinois

  • Investigational Site

    Chicago, Illinois

  • Investigational Site

    Evansville, Indiana

  • Investigational Site

    Louisville, Kentucky

  • Investigational Site

    Glenn Dale, Maryland

  • Investigational Site

    Hunt Valley, Maryland

  • Investigational Site

    Rockville, Maryland

  • Investigational Site

    West Bloomfield, Michigan

  • Investigational Site

    Fridley, Minnesota

  • Investigational Site

    Omaha, Nebraska

  • Investigational Site

    New York, New York

  • Investigational Site

    New York, New York

  • Investigational Site

    Charlotte, North Carolina

  • Investigational Site

    Nashville, Tennessee

  • Investigational Site

    Nashville, Tennessee

  • Investigational Site

    Charlottesville, Virginia

  • Investigational Site

    Spokane, Washington

  • Investigational Site

    Vancouver, B.C., Canada

  • Investigational Site

    Peterborough, Ontario, Canada

  • Investigational Site

    Toronto, Ontario, Canada

  • Investigational Site

    Toronto, Ontario, Canada

  • Investigational Site

    Montreal, Quebec, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.